ALYSSA SIMMARANO: Open Payments
NPI 1417635111 · LEOMINSTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$896 in 24 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $217 · 2025 $896
Food & beverage: $896
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $508 |
| ABBVIE INC. | 6 | $210 |
| Janssen Pharmaceuticals, Inc | 1 | $117 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
Products named: CAPLYTA, VRAYLAR, SPRAVATO, REXULTI.
Industry payments across MA — which companies pay providers there.
